The 4th Annual Gene Therapy for Rare Disorders will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market. Experts from PPD and Evidera will be presenting on challenges encountered in small patient number trials and real-world assessment of commercialization strategies for rare disease gene therapies.
Podium
Real-World Assessment of Commercialization Strategies for Rare Disease Gene Therapies
Panel Discussion